Page last updated: 2024-10-23

azathioprine and Apical Ballooning Syndrome

azathioprine has been researched along with Apical Ballooning Syndrome in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mavrogeni, S1
Ntoskas, T1
Gialafos, E1
Karabela, G1
Krommida, M1
Gatzonis, S1
Siatouni, A1
Kolovou, G1
Zouvelou, V1
Stamboulis, E1

Other Studies

1 other study available for azathioprine and Apical Ballooning Syndrome

ArticleYear
Silent myocarditis in myasthenia gravis. Role of cardiovascular magnetic resonance imaging.
    International journal of cardiology, 2016, Jan-01, Volume: 202

    Topics: Adult; Azathioprine; Cardiac Imaging Techniques; Echocardiography; Female; Humans; Immunosuppressive

2016